IP protection to support sustainable commercial development of microbiome-targeting applications. Discovering the influence of microorganisms on health, disease and wellbeing.
Microbiome targeting technology is a rapidly emerging, complex sector which improves human, animal, and crop health and well-being. Having actively advised on a full-range of IP matters involving manipulation and analysis of microbiomes for almost two decades, HGF has one of the most experienced teams in this area throughout Europe.
Specialising in therapeutic, diagnostic, nutraceutical, cosmetic and agricultural application, as well as related bioinformatics-powered innovations, the team is well versed in the challenges and opportunities for protecting and commercialising the whole spectrum of microbiome-related inventions, and assists the full range of microbiome-focused companies in developing robust IP strategies, including IP protection, freedom to operate, licensing, European patent opposition and litigation strategies.
The Austrian parliament has completed the legislative procedure to ratify the Protocol on the provisional application of the Agreement on a Unified Patent Court (the “Protocol”; see here). When deposited, …Read article
The University of Hong Kong is hosting a webinar on ‘IP Management: AI and 5G in healthcare’ on 9th December 2021 with HGF’s Partner Dr Chris Benson and Patent Director …Event details
A Leeds alumnus has been appointed as the next Pro-Chancellor of the University of Leeds. A lawyer by background, with a strong track record in leadership in education and social …Read article